TGFB1 and prostate cancer: In addition, inhibition of TGFβ is achieved by co-expression in the CAR of a dominant-negative receptor for TGFβ that blocks TGFβ signaling, increasing proliferation and persistence of CAR-T cells in models of prostate cancer (113).